This document discusses different types of rates used to compare disease occurrence between populations and over time. It introduces crude rates, specific rates, and standardized rates. Standardized rates allow for fair comparisons between populations by adjusting for characteristics like age that influence disease risk. The document outlines direct and indirect standardization methods. Direct standardization applies the actual age-specific rates from study populations to a standard population, while indirect standardization applies age-specific rates from a standard population to the age structure of the study populations. Both allow comparison of disease rates between populations after accounting for differences in age distribution.
An overview of a key statistical technique in epidemiology – standardization - is introduced. The process and application of both direct and indirect standardization in improving the validity of comparisons between populations are described.
Standardization of rates by Dr. Basil TumainiBasil Tumaini
Standardization of rates by Dr. Basil Tumaini, presented during the residency at Muhimbili University of Health and Allied Sciences, Epidemiology class
Morbidity has been defined as any departure, subjective or objective, from a state of physiological or psychological well-being. In practice, morbidity encompasses disease, injury, and disability.
The ppt is a short description about how to ascertain the validity, ie; sensitivity and specificity of a screening test as well as their predictive powers. you can also find the technique to ascertain the best possible screening test through the help of an ROC curve...
An overview of a key statistical technique in epidemiology – standardization - is introduced. The process and application of both direct and indirect standardization in improving the validity of comparisons between populations are described.
Standardization of rates by Dr. Basil TumainiBasil Tumaini
Standardization of rates by Dr. Basil Tumaini, presented during the residency at Muhimbili University of Health and Allied Sciences, Epidemiology class
Morbidity has been defined as any departure, subjective or objective, from a state of physiological or psychological well-being. In practice, morbidity encompasses disease, injury, and disability.
The ppt is a short description about how to ascertain the validity, ie; sensitivity and specificity of a screening test as well as their predictive powers. you can also find the technique to ascertain the best possible screening test through the help of an ROC curve...
This PPT discusses
Basics measurements in epidemiology
Basics requirements of measurements
Tools of measurements
Measures of morbidity
Measures of disability
Measures of mortality
Measurements of morbidity and mortality
At the end of the session, the students shall be able to
List the basic measurements in epidemiology
Select an appropriate tools of measurement
Measure morbidity & mortality
Perform standardization of rates
Diagnostic, screening tests, differences and applications and their characteristics, four pillars of screening tests, sensitivity, specificity, predictive values and accuracy
Descriptive Epidemiology (including Measurement in epidemiology)Dr. Animesh Gupta
Basic measurement in epidemiology
Incidence & Prevalence
Tools of measurement in epidemiology
Epidemiological methods
Descriptive epidemiology.
Distribution of disease in term of Time, Place and Person
ICON experts give an in-depth overview of infectious disease modeling with a focus on assessment of interventions and its challenges.
The nature of communicable diseases results in unique epidemiological characteristics that must be accounted for when considering the epidemiological, clinical, and economic consequences of interventions that modify transmission. These interventions clearly include vaccines, but also drug treatments that may reduce the duration of infectiousness.
This webinar outlines the unique epidemiological characteristics of communicable diseases and demonstrates how correctly accounting for these in clinical and economic assessments of interventions can capture the full value of these interventions. Some of the challenges faced when performing these analyses are also addressed.
Key Topics Include:
- Understanding infectious disease modeling
- Why infectious disease modeling is needed
- Challenges associated with infectious disease modeling
Incidence (Epidemiology lecture)
short ppt to understand incidence. primary incidence rate, secondary incidence rate, incidence rate, examples of incidence, incidence rate related question are discussed in this lec.
This PPT discusses
Basics measurements in epidemiology
Basics requirements of measurements
Tools of measurements
Measures of morbidity
Measures of disability
Measures of mortality
Measurements of morbidity and mortality
At the end of the session, the students shall be able to
List the basic measurements in epidemiology
Select an appropriate tools of measurement
Measure morbidity & mortality
Perform standardization of rates
Diagnostic, screening tests, differences and applications and their characteristics, four pillars of screening tests, sensitivity, specificity, predictive values and accuracy
Descriptive Epidemiology (including Measurement in epidemiology)Dr. Animesh Gupta
Basic measurement in epidemiology
Incidence & Prevalence
Tools of measurement in epidemiology
Epidemiological methods
Descriptive epidemiology.
Distribution of disease in term of Time, Place and Person
ICON experts give an in-depth overview of infectious disease modeling with a focus on assessment of interventions and its challenges.
The nature of communicable diseases results in unique epidemiological characteristics that must be accounted for when considering the epidemiological, clinical, and economic consequences of interventions that modify transmission. These interventions clearly include vaccines, but also drug treatments that may reduce the duration of infectiousness.
This webinar outlines the unique epidemiological characteristics of communicable diseases and demonstrates how correctly accounting for these in clinical and economic assessments of interventions can capture the full value of these interventions. Some of the challenges faced when performing these analyses are also addressed.
Key Topics Include:
- Understanding infectious disease modeling
- Why infectious disease modeling is needed
- Challenges associated with infectious disease modeling
Incidence (Epidemiology lecture)
short ppt to understand incidence. primary incidence rate, secondary incidence rate, incidence rate, examples of incidence, incidence rate related question are discussed in this lec.
Study of the distribution and determinants of
health-related states or events in specified populations and the application of this study to control health problems.
John M. Last, Dictionary of Epidemiology
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
CDSCO and Phamacovigilance {Regulatory body in India}
1.6 standardization
1. Types of rates
• Crude rate: number of events in a total population /
person-time for which the population at risk has been
observed
• Specific rates: number of events in a subpopulation /
person-time for which the subpopulation at risk has
been observed (e.g. for age groups)
• Standardized or adjusted rates: have undergone
statistical transformation to permit comparison of rates
across populations or among groups differing in the
distribution of some characteristic (e.g., age) that may
affect the risk of disease
Standardization
2. Comparing crude rates
• A crude rate represents the actual experience of the
population and is thus a valuable way to describe the
disease experience
• Comparing crude rates between two or more
populations can be misleading because populations
may differ with respect to characteristics that affect
morbidity and mortality
• What are some of the principal factors that influence
morbidity and mortality?
Standardization
3. • Consider age-specific rates…
• The crude rate can be thought of as a weighted average
of the age-specific rates
– the weights are the proportion of the population in
each age category
• Crude rate = ∑(age-specific rate x proportion of pop in
that age category)
• Even if two populations had identical age-specific rates,
the crude rates for the two populations would differ if the
age structure of the two populations were different
Standardization
4. • Population 1:
– 500,000 people aged 20-24
– 500,000 people aged 25-29
• Population 2:
– 200,000 people aged 20-24
– 800,000 people aged 25-29
• In both populations
– CI among 20-24 = 0.002
– CI among 25-29 = 0.009
• What are the crude “rates” in populations 1 & 2?
Standardization
5. • Crude rate = ∑(age-specific rate x proportion of pop in that age
category)
• Population 1, crude CI = 0.002*0.5 + 0.009*0.5 = 0.0055
• Population 2, crude CI = 0.002*0.2 + 0.009*0.8 = 0.0076
• What do you think about comparing the health experience of these
two populations using their CI values?
Population 1 Population 2
Age rate proportion rate proportion
20-24 0.002 0.5 0.002 0.2
25-29 0.009 0.5 0.009 0.8
Standardization
6. • Standardization of rates allows direct
comparison of rates between populations
– A standardized rate is a summary rate that has been
adjusted to account for the differences in the
distribution of characteristics that affect disease (e.g.,
age) between populations
– Standardized rates allow fair comparisons to be
made between populations
– Answers the question: what would the death rate be
in each population, if they had identical distributions
of {X}? e.g. age
– Counterfactual idea
Standardization
7. • Compare the death rates in these two states
• Concerns about direct comparison of these crude rates?
– Age structures of the populations of these two states are quite
different
Standardization
8. Direct standardization
• Choose a standard population (e.g., 1990 or 2000 US
population from US Census)
• Use the actual age-specific rates from each study
population (e.g., state)
• Apply these rates to the standard population in each
age category
• Calculate the number of outcomes that would have
been observed in the study population if it had the age
distribution of the standard population – a counterfactual
idea
• Calculate the adjusted rate of the outcome
Standardization
9. • Age adjusted rate = total expected outcomes
total standard population
Standardization
Key for direct adjustment:
Age specific rates come from your study population
Age specific population sizes (i.e, the weights) come from
the standard population
10. • Where to start – set up table with age intervals
• Fill in age specific rates from study population(s)
• Fill in age specific population sizes from standard population (from
outside source, e.g., US Census)
Standardization
Direct Standardization
11. • Calculate expected number of deaths for study population(s) within
age strata
• E = RateStudy*PopulationStandard
• EFL<5 = (179.26/100,000)*18,900,000 = 33,880
Standardization
Direct Standardization
12. • Sum expected deaths for study population(s) and calculate age
adjusted rates
• Rateadj = EStudy/PopulationStandard
• RateadjFL =1,912,628/248,800,000 = 0.007686 = 768.6/100,000
Standardization
Direct Standardization
14. • Choice of standard population
– Distribution of one of the two populations you want to
compare
– Distribution of the two populations combined
– Some outside standard (e.g., US population from
census)
– Choice should be driven by the counterfactual
question you want to ask
• What would the rates be if my two study populations had the
same age structure as population X?
Standardization
15. • Beware: the values you calculate will depend on
the standard population chosen
– Can get different results from different standards if
the standards have notably different age structures
• Note that the actual value of the new adjusted
rate is a product of the choice of a standard
population – it is not a “real” rate
Standardization
16. Pros:
• Directly standardized rates can be used to compare
disease rates across areas and time
Cons:
• Requires age-specific rates that are not often available
at a local level or in certain populations
• Rates may not be stable for small number of events
(approximately <100 events)
Standardization
17. Standardization
• At home exercise (for lab)
– Prostate cancer mortality by race
– White men: 1359 deaths / 4,738,246 men
– 28.7 deaths per 100,000 men
– Black men: 121 deaths / 418,992 men
– 28.9 deaths per 100,000 men
18. Standardization
• At home exercise (for lab)
• Calculate age adjusted rates of prostate cancer
mortality by race
19. • There may be situations in which age-specific rates are
not available for your study population
– Common in occupational studies – number of cases available
from records but unable to reconstruct rates
• You still want to be able to make a comparison between
the disease experience of your study population and
another population accounting for differences in the
distribution of characteristics (e.g., age)
• If you know the age structure of your study population,
indirect standardization is an option
Standardization
20. • Choose a standard population for which rates of your
outcome are available
• Use the age-specific rates from the standard population
• Apply these rates to the study population in each age
category
• Calculate expected number of deaths that would have
occurred in the study population
• This expected number of deaths is counterfactual
– It’s the number of deaths that would have occurred in the study
population if it had the same age-specific rates as the standard
population
• Compare the observed number of deaths in the study
population to the expected number of deaths if the
standard rates applied
Standardization
21. Standardization
• SMR = total observed
outcomes x 100
total expected outcomes
• Standardized morbidity/mortality ratio (SMR):
– Ratio of the observed number of outcomes in the study
population to the expected number of outcomes if the study
population had the same age-specific rates as the standard
population
– Answers question: is the morbidity/mortality experience greater
than, less than, or similar to that which is expected in the
standard population? (if equal, SMR = 100)
22. • Direct vs. indirect standardization
summary
Population used
(weight)
Rate applied
Direct Standard Study
(observed)
Indirect Study
(observed)
Standard
Standardization
23. Key for indirect adjustment:
Age-specific rates come from your standard population
Age-specific population sizes (also called weights) come
from the study population
Standardization
24. • Example: we have data from two health care
organizations on the numbers of occupational injuries
reported
– Health care organization 1: 95
– Health care organization 2: 64
• We are wondering how these health care organizations
compare to the US average for those working in health
care regarding injuries
Standardization
25. • Where to start – set up table with age intervals
• Fill in age-specific rates from standard population
• Fill in age-specific population sizes from study population(s)
Standardization
Indirect Standardization
26. • Calculate expected number of injuries for study population(s) within
age strata
• E = RateStandard*PopulationStudy
• EOrg1,15-30 = (60/10,000)*5700 = 34.2
Standardization
Indirect Standardization
27. • Sum expected injuries for study population(s) and calculate SMR(s)
• SMR = O/E
• SMROrg1 = (95/66.7)*100 = 142
Standardization
Indirect Standardization
28. • Interpret each SMR as a comparison of that study population to the
standard
– Health care organization 1 had a 42% higher rate of injury than the
health care workers in the US population
– Health care organization 2 had a 9% lower rate of injury than the health
care workers in the US population
• You cannot compare SMRs to each other
Standardization
Indirect Standardization
29. Pros:
• Indirect standardization does not require age-specific rates, only
total number of events in the study population and age structure of
the study population
Cons:
• SMRs cannot be directly compared
– Each SMR captures a counterfactual comparison within that
specific population
• E.g, Observed deaths from pop A/Expected deaths from pop A (if
standard rates applied)
– The two study populations may have different age structures
and the expected deaths depends on the age structure of each
study population
• Unlike directly standardized rates, SMRs give no idea of the actual
burden of disease
Standardization
30. Standardization
• Examining the lack of comparability of SMRs by uncovering the
true age-specific injury rates in our two health care organizations
32. Standardization
• Why are the SMRs so different?
• Org 1 has a younger population and the age-specific rates in that
younger population are higher than in the standard
• Org 2 has an older population and the age-specific rates in that older pop
are lower than in the standard
• Each SMR is a comparison of one study population to the standard – not
a comparison of one study population to another
33. • Direct vs. indirect standardization
summary
Population used
(weight)
Rate applied
Direct Standard Study
(observed)
Indirect Study
(observed)
Standard
Standardization